Bioimpact Llc Mpm serves as Executive at Werewolf Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Bioimpact Llc Mpm has executed 3 insider transactions totaling $183.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 4, 2025 involved selling 83,230 shares valued at $80.7K.
Bioimpact Llc Mpm currently holds 4,784,111 shares of Werewolf Therapeutics, Inc. (HOWL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioimpact Llc Mpm has been a net seller of HOWL stock. They have purchased $0 and sold $183.3K worth of shares.
Bioimpact Llc Mpm's most recent insider trade was on Dec 4, 2025, when they sold 83,230 shares at $0.97 per share.
Get notified when new Form 4 filings are submitted
| $0.87 |
| Discretionary |
| Dec 2, 2025 | HOWL | $52.8K | Sale | 59,277 | $0.89 | Discretionary |